A new vaccine for Europe
A new vaccine (“Nuvaxovid”) from the American biotech company Novavax has been approved by the European Medicines Agency (EMA).
A new vaccine (“Nuvaxovid”) from the American biotech company Novavax has been approved by the European Medicines Agency (EMA).
After the Advisory Committee on Ethics, the French National Authority for Health (HAS) has just given its green light to the vaccination of children aged 5 to 11, but without obligation. Still happy!
“It is not acceptable that the refusal of a few million French people to be vaccinated puts at risk the life of a whole country!” stressed the Prime Minister to justify the new restrictions aimed at containing the epidemic of Covid-19.
Should we change our vaccination strategy since mass vaccination with two, three and soon four doses fails to eradicate the Covid-19 epidemic? The scientific controversy is growing.
This is in response to a new wave of Covid-19-related hospitalizations.
Despite mass vaccination the fifth wave of the Covid-19 epidemic continues to rise with 61,340 new cases in 24 hours. Prof. Jean-François Delfraissy mentions a possible 4ᵉ dose of vaccination.
The scientific community speaks out against the health policy of the authorities: the declaration of Great Barrington (USA) against massive injections of mRNA has collected 870.000 signatures.
Jean-Marc Sabatier, Director of Research at the CNRS and Doctor of Cell Biology and Microbiology, has doubts about mandatory vaccination. Because vaccines have lost their initial effectiveness. And the Omicron variant, although contagious, does not cause serious forms of the disease.
The SARS-CoV-2 epidemic seems to be resuming in France, which has recorded 47,177 additional cases in the last 24 hours, according to Santé Publique France, and 10,249 people are currently hospitalized.
But what do we really know about this variant? Is it more contagious, more dangerous? The molecular analysis of Jacques Fantini, professor of Biochemistry and Molecular Biology at the University of Aix-Marseille.
Highly contagious, this new variant impacts the financial markets and calls into question the vaccine strategy since the current vaccines are designed to counter the initial Wuhan strain which has completely disappeared.
The European Medicines Agency (EMA) approves this November 25, 2021 the vaccination of children aged 5 to 11 years. A “crazy decision” for many scientists. Who will be legally responsible?